Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 24

Trial Status

Completed4
Terminated1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT01286038Phase 1Terminated
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
Myelodysplastic Syndrome (MDS)Thrombocytopenia
PrincipalinvestigatorStart date: 2011-04-06
NCT01133275Phase 2Completed
Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
MDSMyelodysplastic Syndrome
PrincipalinvestigatorStart date: 2010-04-28
NCT00977548Phase 2Completed
Erlotinib Study for Myelodysplastic Syndrome (MDS)
Myelodysplastic Syndrome
Principalinvestigator
NCT01822691Phase 2Completed
Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

H. Lee Moffitt Cancer Center and Research Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Neal S Young, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Myelodysplastic Syndrome (MDS)Myelodysplastic SyndromesThrombocytopenia

Worked with same sponsors:

Novartis
Similarity Score18%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesMDS

Worked with same sponsors:

Celgene CorporationIncyte Corporation
Similarity Score18%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic Syndromes
Similarity Score12%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic Syndromes

Worked with same sponsors:

Celgene CorporationNovartis
Similarity Score12%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic Syndromes

Worked with same sponsors:

GlaxoSmithKlineNovartis
Similarity Score12%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic Syndromes
Similarity Score12%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic Syndromes
Similarity Score12%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Leukemia
Similarity Score6%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

Leukemia
Similarity Score6%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Leukemia
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT01286038Phase 1PrincipalInvestigator

Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

Myelodysplastic Syndrome (MDS)Thrombocytopenia
Terminated
NCT01133275Phase 2PrincipalInvestigator

Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS

MDSMyelodysplastic Syndrome
Completed
NCT00955916Phase 2PrincipalInvestigator

CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Leukemia
Completed
NCT00977548Phase 2PrincipalInvestigator

Erlotinib Study for Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome
Completed
NCT01822691Phase 2PrincipalInvestigator

Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes
Completed

All 5 trials loaded